News and Insights

FINN Partners appoints Jessica Lise as Managing Partner, New York Health Group Lead

November 17, 2026

Jessica Lise builds on the foundation established by predecessor Tom Jones, advancing client success, talent development and continued growth

FINN Partners, a global independent marketing and communications agency, today announced the appointment of Jessica Lise as Managing Partner and New York Health Group Lead. Lise succeeds Tom Jones, building on his contributions to client service and agency growth as he concludes his tenure with FINN Partners to relaunch his consultancy, advising senior leaders on industry communications.

Lise has built a reputation on her understanding of the life-science sector, strategic counsel and ability to rally teams around client success. Her track record in retaining and expanding client accounts reflects her expert counsel and the talented colleagues she has helped develop and retain. She will report to Gil Bashe, Chair Global Health & Purpose, and continue to serve on the Global Health Leadership Group, led by Fern Lazar, Managing Partner and Global Health Practice Lead.

“One of FINN Partners’ greatest strengths is the extraordinary talent, heart and determination of our people and the shared commitment that drives our work,” said Lise. “I am grateful for the opportunity to lead a Group dedicated to helping life science companies communicate the value of their innovations and improve people’s lives. I look forward to building on our collective achievements, strengthening collaboration with FINN colleagues around the world, and creating new opportunities for our team and clients to grow and succeed.”

“Biopharma and life sciences companies face mounting pressure to demonstrate value, secure market access and reach patients with information that can sustain and save lives,” said Bashe. “Success requires communications partners who understand the science, business realities, regulatory parameters and stakeholders who influence market success. Jess anticipates clients’ needs and brings out the best in colleagues to achieve those goals. Her appointment reflects an outstanding track record and our confidence in her leadership.”

Since joining FINN Partners in 2019, Lise has taken on a series of senior leadership roles, advising clients ranging from top-10 biopharmaceutical companies to emerging innovators. She has helped companies and not-for-profit associations translate complex science into compelling narratives, rally health professionals, advocates and consumers around shared goals and strengthen their market voice in an increasingly competitive health sector.

“Our Global Health Practice brings together exceptional talent across five continents, united by a shared commitment to making a difference through our clients,” said Lazar. “Jess has been a valued member of our Global Health Leadership Group, bringing ideas, generosity and a genuine dedication to helping others succeed. She embodies the collaborative culture that defines FINN Partners, where colleagues champion one another and share in each other’s success.”

Jones concludes his seven-year tenure with FINN Partners, during which his leadership helped establish the New York Health Group as a key part of the FINN Global Health Practice and expand its presence in the biopharma sector. He built a vibrant community of colleagues committed to client service and improving people’s lives, developing a strong bench of talent to lead the Group into its next chapter.

“Tom helped build a Group that has become a central part of the FINN Global Health Practice,” said Bashe. “I am grateful for his partnership and the many contributions that have made the FINN Global Health Practice among the industry’s most sought-after partners. I wish him great success as he begins the next career adventure.”

FINN Partners’ Global Health Practice serves clients across the biopharma, biotechnology, medical technology, digital health and information and provider services sectors, as well as NGOs, foundations and patient organizations. With teams spanning five continents and 130 countries, the Practice integrates scientific and medical expertise with earned and social media, corporate and product positions, investor relations, digital marketing, patient advocacy and health policy expertise. Operating across developed and emerging markets, the Practice helps clients bring innovations to market, navigate access challenges, strengthen reputations and champion better health outcomes worldwide.